News Detail
Washington, 15 June 2024 (Reuters) The U.S. health regulator has changed its strain recommendation for the 2024-25 COVID-19 vaccines, as it asked manufacturers to update the new shots to target the KP.2 variant, if feasible, instead of the JN.1 lineage it sought to targe......
View Details
Source : Reuters
KP.2 variant
COVID-19 vaccines
JN.1 lineage
Food and Drug Administration
Novavax
Moderna
Related News
- DCA Seizes Overpriced, misleading claim Medicine (26-06-2024)
- Inquiry demanded at Maharashtra Assembly on export nod for over 200 pharma companies without stability testing (26-06-2024)
- Spurious drug factory busted in Gandhinagar (26-06-2024)
- Gang involved in illegal drug trade busted; 11 arrested (26-06-2024)
- 90% of healthcare companies get a 'B+' on cybersecurity with medical devices (26-06-2024)
- US lawmakers questions FDAs drug inspection programme in India and China (25-06-2024)
- Two arrested with 36,000 bottles of banned cough syrup in Siliguri (25-06-2024)
- DoP further expands list of special invitees into committee constituted to reform pricing framework (25-06-2024)
- India key market for APIs, but patients forced to cough up crores to buy orphan drugs (25-06-2024)
- Govt considers ban on two antibiotics for poultry and animal feed supplements (25-06-2024)